Mount Yale Investment Advisors, LLC Fibrogen Inc Transaction History

Mount Yale Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $13,175 - $20,875	-347 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $16,721 - $19,973	-297 Reduced 46.12%	347 $15,000
Q2 2018 Aug 22, 2018	BUY	$44.9 - $64.95 $13,514 - $19,549	301 Added 87.76%	644 $40,000
Q1 2018 Jun 25, 2018	BUY	$45.35 - $61.65 $15,555 - $21,145	343 New	343 $16,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.